BP000997-C060: Recombinant Human Beta-Nerve Growth Factor (β-NGF) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells was less than1.0 ng/ml. Corresponding to a specific activity of > 1 x 106 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000997-CYT-079: Recombinant Human β-Nerve Growth Factor (β-NGF) Protein, HEK
Source: HEK-derived.
The specific activity was determined by the dose-dependent stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) and is typically 1.5-8 ng/ml.
Purity: > 95% by SDS?PAGE.BP000997-CYT-246: Recombinant Human β-Nerve Growth Factor (β-NGF) Protein, CHO
Source: Chinese Hamster Ovary Cells-derived.
The ED50, calculated by its ability to stimulate chick E9 DRG neurite outgrowth was found to be < 1.0 ng/ml, corresponding to a specific activity of > 1,000,000 units/mg.
Purity: > 98% by SDS?PAGE and RP-HPLC.BP000997-CYT-440: Mouse β-Nerve Growth Factor (β-NGF) Protein
Source: Submaxillary Gland of Grown Mouse-derived.
The method used to test the bioassay is the NGF-dependent survival of dorsal root ganglia neurons of chick embryo, corresponding to a Specific Activity of 500,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000997-CYT-579: Recombinant Human β-Nerve Growth Factor (β-NGF) Protein
Source: E. coli-derived.
The ED50, calculated by its ability to stimulate chick E9 DRG neurite outgrowth was found to be < 1.0 ng/ml, corresponding to a specific activity of > 1,000,000 units/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000997-CYT-581: Recombinant Mouse β-Nerve Growth Factor (β-NGF) Protein
Source: E. coli-derived.
The Mouse b-NGF activity was measured in a cell proliferation assay using a factor-dependent human erythroleukemic cell line, TF-1, the ED50 for this effect is 0.2 ng/ml corresponding to a Specific Activity of 5 MIU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000997-GD23: Recombinant Human Beta-Nerve Growth Factor (β-NGF) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells was less than1.0 ng/ml. Corresponding to a specific activity of > 1 x 106 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).C040P: Alemtuzumab Biosimilar, CD52 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody alemtuzumab biosimilar specifically binds to the human CD52, a protein present on the surface of mature lymphocytes.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by alemtuzumab.